COVID-19: Background, Symptoms & Transmission

By Gagandeep Sachdeva

 Disclaimer: The information for the upcoming series of posts on the Coronavirus has been collated from a range of sources and the purpose is to provide insight into the virus from an objective lens. These posts are accurate to the time of publication; however, our knowledge of the virus is rapidly evolving, so we recommend for you to stay up to date with the latest news broadcasts and research.


 The new Coronavirus (COVID-19) has been declared as a global health emergency by the World Health Organisation (WHO), with over 935,000 cases and over 47,000 deaths from across 203 countries and territories as of 12:30pm on 2nd April 2020 (1,2). Multiple organisations have published research on the virus and over a series of posts, we will explore the findings to get you up to date with this outbreak.

This post will explore the scientific details of the virus, the symptoms observed and transmission.

The 2019 Coronavirus disease (COVID-19) is caused by SARS-COV-2, a virus that primarily targets the respiratory epithelium (3). It belongs to a Coronavirus family of single-stranded RNA viruses (4). A Coronavirus pandemic was seen in 2002 (SARS-COV-1), with genomic studies showing an 80% matched genetic identity of this virus with COVID-19 (3). COVID-19 is likely of zoonotic origin, based on the large number of infected people who were exposed to the wet animal market in Wuhan, China. Genetic sequencing has shown 88% resemblance of COVID-19 infecting humans, with the virus in bats, suggesting a potential source and reservoir of the virus (3).

Viruses are obligate intracellular parasites, meaning they must be internalised into host cells to replicate and cause disease. COVID-19 has surface ‘spike-like’ glycoproteins which bind a human cell membrane enzyme (called ACE2) with high affinity, permitting cell entry (5). Viral replication then commences and the increasing viral load exacerbates the disease. Luckily, the body’s immune system is the defense against pathogens, and the foreign viral markers initiate an inflammatory response with the aim to fight off the infection.

The immune system’s response is what produces the symptoms of the disease. In the case of COVID-19, the key symptoms as outlined by NHS UK (6) are:
  • High temperature
  • New, continuous cough: “coughing a lot for more than 1 hour, or 3 coughing episodes in past 24 hours (if usually have a cough, it may be worse than usual)”
  • Other symptoms may include headache, shortness of breath, sputum production and diarrhoea
The virus has been calculated to have approximately a 5-day incubation period (the time from exposure to the virus, to the onset of symptoms), with initially mild symptoms at presentation and progression to pneumonia at day 9 of illness (3). 80% of patients experience mild symptoms, however vulnerable groups including the elderly and those with underlying health conditions, have a risk of severe infection and respiratory compromise which could be fatal. This is evidenced by the unfortunate higher mortality rate from the virus in the elderly population.

The predominant modalities of transmission of COVID-19 are airborne droplets (coughs and sneezes) and contact with infected people and surfaces. The virus is highly contagious, with estimated figures suggesting 1 person on average passes the virus onto 2.2 people. This spread rate is referred to as the R0 value. For context, the seasonal flu has R0 of 1.3, while the deadly Spanish flu of 1918 had an R0 value estimated between 1.4-2.8 (7).

The enforcement of lockdown and quarantine aims to reduce the spread of COV-19. 7-day self-isolation has also been advised by NHS UK if an individual or someone they live with has symptoms of COVID-19. Extension of this self-isolation is advised if the individual still has a high temperature.

We hope that this post has been informative. Please continue to quarantine and strictly follow policies from local authorities and the Government.

 References:  
1. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen  
2. https://www.worldometers.info/coronavirus/ 
3. https://www.sciencedirect.com/science/article/pii/S0896841120300469 
4. https://www.ncbi.nlm.nih.gov/books/NBK554776/ 
5. https://cen.acs.org/analytical-chemistry/structural-biology/Structure-novel-coronavirus-spike-protein/98/i8 
6. https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms-and-what-to-do/ 
7. https://www.healthline.com/health/r-nought-reproduction-number#rsubsubvalues 
8. https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/ 

Comments

Post a Comment

Popular posts from this blog

PTSD - A Psychodynamic Explanation

Post-traumatic stress disorder (PTSD) is a type of anxiety disorder which you may develop after being involved in, or witnessing, traumatic events. The condition was first recognised in war veterans and has been known by a variety of names, such as 'shell shock'. PTSD can develop immediately after someone experiences a disturbing event, or it can occur weeks, months or even years later. Its estimated to affect about 1 in every 3 people who have a traumatic experience, but it's not clear exactly why some people develop the condition and others do not. There are many theories that could be used to explain this condition. Psychodynamic approaches to PTSD focus on a number of different factors that may influence or cause PTSD symptoms, such as early childhood experiences, current relationships and the things people do to protect themselves from upsetting thoughts and feelings that are the result of experiencing a traumatic event. The psychodynamic approach focuses mainly
Read more

Disparities in Global Eye Care

Vision is one of our most precious possessions. Multiple polls globally show that most people are more fearful of becoming blind than losing any other sense. (1,2) With sight being such a valuable asset, one would assume that eyecare is at the forefront of medical services across the world. Living in the developed world, we perhaps take for granted the simple and yet crucial services available to us such as regular eye tests, glasses, contact lenses and high-quality ophthalmic care - most of which can be accessed for free or at a subsidised price. However, in many parts of the world this is not the case. 285 million people worldwide are visually impaired, with 90% being from developing countries. (3) In China, for example, levels of blindness are increasing each year, however critically, rates of blindness have been reported at up to 4 times higher in the developing world as compared to more economically developed countries (4, 5). This is particularly worrying given that around 80% of
Read more

Do Contact Lenses Really “Support Your Vision”?

Image
Contact lenses have been frequently used as an alternative to glasses. Compared to the heavy-framed glasses in front of one’s eyes (optic glasses), thin plastic discs on the eye (contact lenses) help correct refractive errors in both myopic and hypermetropic users. The lens’ shape and power can be tailored to the user’s sight. A concave lens can be used to decrease myopia by reducing light refraction and increasing focal length so that the image is formed on the retina (1)  (Figure 1). Alternatively, a convex lens can be used to limit hypermetropia in an opposing mechanism to concave lenses (1) (Figure 1). Figure 1, An illustration of myopia and hyperopia and how adding lens of different shapes in front of the eye can be used to alter the refraction of light and correct each impairment in vision (10) Besides supporting sight, which both types of lenses can do, contact lenses confer some advantages that make them preferable to glasses. Unlike glasses, contact lenses are less likely to f
Read more